Literature DB >> 25112875

The roles of the RIIβ linker and N-terminal cyclic nucleotide-binding domain in determining the unique structures of the type IIβ protein kinase A: a small angle x-ray and neutron scattering study.

Donald K Blumenthal1, Jeffrey Copps2, Eric V Smith-Nguyen2, Ping Zhang2, William T Heller3, Susan S Taylor4.   

Abstract

Protein kinase A (PKA) is ubiquitously expressed and is responsible for regulating many important cellular functions in response to changes in intracellular cAMP concentrations. The PKA holoenzyme is a tetramer (R2:C2), with a regulatory subunit homodimer (R2) that binds and inhibits two catalytic (C) subunits; binding of cAMP to the regulatory subunit homodimer causes activation of the catalytic subunits. Four different R subunit isoforms exist in mammalian cells, and these confer different structural features, subcellular localization, and biochemical properties upon the PKA holoenzymes they form. The holoenzyme containing RIIβ is structurally unique in that the type IIβ holoenzyme is much more compact than the free RIIβ homodimer. We have used small angle x-ray scattering and small angle neutron scattering to study the solution structure and subunit organization of a holoenzyme containing an RIIβ C-terminal deletion mutant (RIIβ(1-280)), which is missing the C-terminal cAMP-binding domain to better understand the structural organization of the type IIβ holoenzyme and the RIIβ domains that contribute to stabilizing the holoenzyme conformation. Our results demonstrate that compaction of the type IIβ holoenzyme does not require the C-terminal cAMP-binding domain but rather involves large structural rearrangements within the linker and N-terminal cyclic nucleotide-binding domain of the RIIβ homodimer. The structural rearrangements are significantly greater than seen previously with RIIα and are likely to be important in mediating short range and long range interdomain and intersubunit interactions that uniquely regulate the activity of the type IIβ isoform of PKA.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cyclic AMP (cAMP); Intrinsically Disordered Protein; Protein Domain; Protein Dynamic; Protein Kinase A (PKA); Protein Structure; Small Angle Neutron Scattering (SANS); Small Angle X-ray Scattering (SAXS)

Mesh:

Substances:

Year:  2014        PMID: 25112875      PMCID: PMC4192500          DOI: 10.1074/jbc.M114.584177

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP.

Authors:  Kerri M Zawadzki; Susan S Taylor
Journal:  J Biol Chem       Date:  2003-11-18       Impact factor: 5.157

2.  Differential effects of substrate on type I and type II PKA holoenzyme dissociation.

Authors:  Dominico Vigil; Donald K Blumenthal; Simon Brown; Susan S Taylor; Jill Trewhella
Journal:  Biochemistry       Date:  2004-05-18       Impact factor: 3.162

3.  C subunits binding to the protein kinase A RI alpha dimer induce a large conformational change.

Authors:  William T Heller; Dominico Vigil; Simon Brown; Donald K Blumenthal; Susan S Taylor; Jill Trewhella
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

4.  Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

Authors:  L S Kirschner; J A Carney; S D Pack; S E Taymans; C Giatzakis; Y S Cho; Y S Cho-Chung; C A Stratakis
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  Defective cardiac ryanodine receptor regulation during atrial fibrillation.

Authors:  John A Vest; Xander H T Wehrens; Steven R Reiken; Stephan E Lehnart; Dobromir Dobrev; Parag Chandra; Peter Danilo; Ursula Ravens; Michael R Rosen; Andrew R Marks
Journal:  Circulation       Date:  2005-04-26       Impact factor: 29.690

Review 6.  Creating order from chaos: cellular regulation by kinase anchoring.

Authors:  John D Scott; Carmen W Dessauer; Kjetil Taskén
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-08       Impact factor: 13.820

7.  Mutation of an A-kinase-anchoring protein causes long-QT syndrome.

Authors:  Lei Chen; Michelle L Marquardt; David J Tester; Kevin J Sampson; Michael J Ackerman; Robert S Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

8.  Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.

Authors:  Lionel Groussin; Eric Jullian; Karine Perlemoine; Albert Louvel; Bruno Leheup; Jean Pierre Luton; Xavier Bertagna; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

9.  Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.

Authors:  Yanan Cao; Minghui He; Zhibo Gao; Ying Peng; Yanli Li; Lin Li; Weiwei Zhou; Xiangchun Li; Xu Zhong; Yiming Lei; Tingwei Su; Hang Wang; Yiran Jiang; Lin Yang; Wei Wei; Xu Yang; Xiuli Jiang; Li Liu; Juan He; Junna Ye; Qing Wei; Yingrui Li; Weiqing Wang; Jun Wang; Guang Ning
Journal:  Science       Date:  2014-04-03       Impact factor: 47.728

10.  Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.

Authors:  Gerald Goh; Ute I Scholl; James M Healy; Murim Choi; Manju L Prasad; Carol Nelson-Williams; John W Kunstman; John W Kuntsman; Reju Korah; Anna-Carinna Suttorp; Dimo Dietrich; Matthias Haase; Holger S Willenberg; Peter Stålberg; Per Hellman; Göran Akerström; Peyman Björklund; Tobias Carling; Richard P Lifton
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

View more
  1 in total

1.  Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).

Authors:  Bryan VanSchouwen; Rajeevan Selvaratnam; Rajanish Giri; Robin Lorenz; Friedrich W Herberg; Choel Kim; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.